Your health starts in your genes

bt_bb_section_bottom_section_coverage_image
AMS Laborator Genetic facilitates access to your unique genetic information so you can take control of your health.
Being healthy means being informed!

How testing helps?

Eating right, exercising, and getting routine checkups (like an annual well-woman visit) are great for the average person. But what if you’re not average? Your genes can tell you if there’s something more you should be doing to improve your health or stay healthy, including:

  • Lifestyle changes
  • Early action to prevent the onset of disease
  • More frequent or earlier screenings for a particular condition or disease

Why should you test?

1 in 6 healthy adults is at increased risk for a serious health condition due to their genetics—and probably doesn't know it.1

When it comes to your health, one size doesn’t fit all!

77% of people say they’d likely take a test if it would help them develop a personalized health plan.1 There’s nothing more personal than your genes.

Invest in your health!

From green juice to home workout equipment, you’re already prioritizing things that support your health.

But did you know that genetic testing can help you make the most of those investments by helping you decide where you may need to focus your health habits?

Genetic testing can tell you if you could benefit from:

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2021/12/aziz-acharki-U3C79SeHa7k-unsplash-scaled.jpg?resize=640%2C480&ssl=1

Changing your lifestyle, diet, or exercise routine

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2021/12/johny-georgiadis-3ewkNkfJj2k-unsplash-scaled.jpg?resize=640%2C480&ssl=1

Seeing a specialist

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2021/12/adam-niescioruk-hWzrJsS8gwI-unsplash-scaled.jpg?resize=640%2C480&ssl=1

Starting or stopping certain treatments, medications, or supplements

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2022/02/screening-medical-e1643799348748.jpg?resize=640%2C480&ssl=1

Increasing medical screenings so you can act early, when treatment is most effective

Hereditary genetic screening panels

Teste

Test

Details

Biological sample

Method

Standard Hereditary Screening Panel**

Hereditary Panel 8 Cancers for: breast, ovary, colorectal, melanoma, pancreas, stomach and uterine body cancers, (including BRCA1 and BRCA2).
30 genes analyzed: APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A (p14ARF and p16INK4a), CHEK2, EPCAM, GREM1, MITF, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, and TP53.
VUS reported

Saliva/ blood

NGS

BRCA Extended Screening Panel**
(BRCA+17)

For breast, ovary and uterine body cancers.

19 genes analyzed: BRCA1, BRCA2, ATM, BARD1, BRIP1, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH, PTEN, PALB2, PMS2, RAD51C, RAD51D, TP53, STK11.
VUS reported
Saliva/ blood

NGS

Cancer Screen Full Panel**

For breast, ovarian, uterine, colorectal, melanoma, gastric, pancreatic, prostate, renal and thyroid cancers.

61 genes analyzed: APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN2A, CHEK2, DICER1, EPCAM, FH, FLCN, GREM1, HOXB13, KIT, MAX, MEN1, MET, MITF, MLH1, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PDGFRA, PMS2, POLD1, POLE, PRKAR1A, PTCH1, PTEN, RAD51C, RAD51D, RB1, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, STK11, TMEM127, TP53, TSC1, TSC2, VHL, WT1M127, TP53, TSC1, TSC2, VHL, WT1.
Reporting for pathogenic and potentially pathogenic variants.
No VUS reported
Saliva/ blood

NGS

Multi-Cancer Diagnostic Panel

For breast, ovarian, uterine, colorectal, gastric, pancreatic, thyroid, paraganglion / pheochromocytoma, parathyroid, pituitary, renal / urinary tract, prostate, melanoma, basal cell carcinoma, brain / nervous system, hematological sarcoma (myelodysplastic syndrome) cancers
84 genes analyzed: AIP ALK APC ATM AXIN2 BAP1 BARD1 BLM BMPR1A BRCA1 BRCA2 BRIP1 CASR CDC73 CDH1 CDK4 CDKN1B CDKN1C CDKN2A CEBPA CHEK2 CTNNA1 DICER1 DIS3L2 EGFR EPCAM FH FLCN GATA2 GPC3 GREM1 HOXB13 HRAS KIT MAX MEN1 MET MITF MLH1 MSH2 MSH3 MSH6 MUTYH NBN NF1 NF2 NTHL1 PALB2 PDGFRA PHOX2B PMS2 POLD1 POLE POT1 PRKAR1A PTCH1 PTEN RAD50 RAD51C RAD51D RB1 RECQL4 RET RUNX1 SDHA SDHAF2 SDHB SDHC SDHD SMAD4 SMARCA4 SMARCB1 SMARCE1 STK11 SUFU TERC TERT TMEM127 TP53 TSC1TSC2 VHL WRN WT1
Saliva/ blood

NGS

Hereditary CaProstate Panel **
(CaP-12)

For prostate cancer
12 genes analyzed: ATM, BRCA1, BRCA2, CHEK2, EPCAM, MLH1, MSH2, MSH6, NBN, PMS2, TP53, PALB2.
Saliva

NGS

Colorectal and Gastric Panel (19 genes)**

For colorectal and gastric cancers
19 genes analyzed: APC, BMPR1A, BRCA1, BRCA2, CDH1, CHEK2, EPCAM, GREM, MLH1, MSH2, MSH6, MUTYH, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53.
Saliva

NGS

Cardiology Genetic Panel ** (arrhythmias & cardiomyopathies)

Genetic testing of up to 150 genes * associated with hereditary primary arrhythmia and / or cardiomyopathy, as well as syndromic causes of cardiomyopathy.
Saliva

NGS

Family program

If a family member is identified with a mutation, we offer genetic testing to first-degree relatives (parents, siblings, children) at very low prices.
The family program does not apply to SUVs

Reference

  1. Haverfield E, Esplin ED, Aguilar S, et al. Multigene panel screening for hereditary disease risk in healthy individuals. Poster presented at: ACMG Annual Meeting; April 12, 2018; Charlotte, NC.